CME REVIEW ARTICLEEfficacy and safety of sublingual immunotherapy
REFERENCES (88)
Prophylactic inoculation against hay fever
Lancet
(1911)- et al.
Fatalities from immunotherapy and skin testing
J Allergy Clin Immunol
(1987) - et al.
Survey of fatalities from skin testing and immunotherapy
J Allergy Clin Immunol
(1993) - et al.
Allergic rhinitis and its impact on asthma
J Allergy Clin Immunol
(2001) - et al.
Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis
Lancet
(1998) - et al.
Clinical and immunological effects of a rush sublingual immunotherapy to Parietaria species: a doubleblind, placebo-controlled trial
J Allergy Clin Immunol
(1999) - et al.
Doubleblind placebo-controlled evaluation of sublingual swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis
J Allergy Clin Immunol
(1999) Spadolini I, Panzani RC. Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica: a double blind study
Allergol Immunopathol (Madr)
(2001)- et al.
Sublingual immunotherapy in tree pollen allergy: doubleblind, placebo-controlled study with a biologically standardized extract of tree pollen (alder, birch and hazel) administered by a rush schedule
Allergol Immunopathol (Madr)
(2001) - et al.
Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite sensitive patients with rhinitis and asthma: a placebo controlled study
Ann Allergy Asthma Immunol
(1999)
Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions
J Allergy Clin Immunol
(1995)
Systemic reactions from allergen immunotherapy
J Allergy Clin Immunol
(1992)
Severe anaphylaxis to kiwi fruit: immunologic changes related to successful sublingual allergen immunotherapy
J Allergy Clin Immunol
(2003)
Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy
J Allergy Clin Immunol
(2003)
Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes to healthy human beings
J Allergy Clin Immunol
(1997)
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)
J Allergy Clin Immunol
(2002)
Determinants of patient compliance with allergen immunotherapy
J Allergy Clin Immunol
(1993)
Non injection routes for immunotherapy
J Allergy Clin Immunol
(2003)
Advances in upper airway disease and allergen immunotherapy
J Allergy Clin Immunol
(2003)
Sublingual immunotherapy
J Allergy Clin Immunol
(2001)
The oral administration of pollen
J Lab Clin Med
(1927)
Bronchial hypersensitization and hyposensitization in man
Int Arch Allergy Appl Immunol
(1951)
Local nasal desensitization in allergic rhinitis
Clin Allergy
(1972)
Orally administered grass pollen
Allergy
(1983)
CSM update: desensitizing vaccines
BMJ
(1986)
Position paper: immunotherapy
Allergy
(1993)
Low dose sublingual therapy in patients with allergic rhinitis due to dust mite
Clin Allergy
(1986)
Allergen immunotherapy: therapeutic vaccines for allergic diseases, Geneva: January 27–29, 1997
Allergy
(1998)
Local immunotherapy
Allergy
(1998)
Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite: a double blind study
Allergol Immunopathol (Madr)
(1990)
A double blind placebo controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract
Allergy
(1994)
Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts: a double blind study
Allergol Immunopathol (Madr)
(1995)
Sublingual immunotherapy in Parietaria pollen induced rhinitis: a double blind study
J Investig Allergol Clin Immunol
(1995)
Double blind placebo controlled study of sublingual immunotherapy with house dust mite extracts in children
Pediatr Allergy Immunol
(1997)
Clinical efficacy of sublingual swallow immunotherapy: a double blind placebo controlled trial of a standardized five grass pollen extract in rhinitis
Allergy
(1998)
Immunotherapy with sublingual birch pollen extract: a short term double blind study
J Investig Allergol Clin Immunol
(1998)
Doubleblind, placebo-controlled evaluation of sublingual immunotherapy with a standardized olive tree pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive tree pollen sensitization
Allergy
(1998)
Sublingual immunotherapy with a standardized grass pollen extract: a double blind placebo controlled study
Allergol Immunopathol (Madr)
(1998)
Sublingual swallow immunotherapy (SLIT) in patients with asthma due to house dust mites: a double blind placebo controlled study
Allergy
(1999)
Sublingual immunotherapy: a doubleblind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma or both
Allergy
(1999)
Sublingual swallow immunotherapy (SLIT) with a standardized five grass pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis
Allergy
(1999)
House dust mite sublingual swallow immunotherapy in perennial rhinitis: a double blind placebo controlled study
Allergy
(2000)
Clinical and immunological effects of longterm sublingual immunotherapy in asthmatic children sensitized to mite: a double blind study
Allergy
(2000)
Preseasonal local allergoid immunotherapy to grass pollen in children: a doubleblind, placebo-controlled, randomized trial
Allergy
(2000)
Cited by (0)
Supported by an unrestricted educational grant from AstraZeneca LP
Copyright © 2004 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.